Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+72.0%
5Y CAGR+4.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+72.0%/yr
vs -21.5%/yr prior
5Y CAGR
+4.1%/yr
Recent acceleration
Acceleration
+93.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $34.33M | +37.4% |
| 2024 | $24.99M | +37.6% |
| 2023 | $18.16M | +169.3% |
| 2022 | $6.74M | +244.7% |
| 2021 | $1.96M | -93.0% |
| 2020 | $28.09M | +18.2% |
| 2019 | $23.76M | +33.9% |
| 2018 | $17.75M | +138.2% |
| 2017 | $7.45M | +114.1% |
| 2016 | $3.48M | - |